On the mid‑tier squeeze – too big to exit, too small to absorb the shock

Mid‑tier insurers face the harshest combination of capital pressure, regulatory scrutiny and limited strategic options. However, in the UK the ‘squeeze’ is primarily shaped by cost shocks and tighter funding conditions in a smaller market, while being rapidly hit by energy, wages, and interest rates.

Bank-led financing and a cautious investment environment present significant constraints to growth. So, in the UK, mid-tier insurers face limited domestic scale and fewer exit paths than in the US. This leaves many firms caught between mounting capital requirements and heighten regulatory scrutiny. Exiting the market could leave to significant disruption, and yet many of the mid-tier companies are too small to weather the financial and operational shocks that are reshaping the sector.

Too large to pivot quickly

Mid-tier companies are often too large to pivot quickly yet too small to match platform-level efficiency. Yet, while the impact can in some case be similar, in the US, the drivers of the mid-tier squeeze are about the economics of scale, geographical presence, and capital market intensity. For example, dominant national players with a wider geographical spread can often outspend mid-sized firms on technology, marketing, and labour.

Nevertheless, fragmented regulation and high fixed costs make doing nothing expensive and potentially highly risky. The challenge is that mid-tier companies are often too large to pivot quickly yet too small to match platform-level efficiency. Patrick Abbe, Executive Managing Director of Aon, nevertheless, speaking from a US perspective, doesn’t fully agree with the argument:

“In the US the exposure for mid-tier companies is not across the board. There are a number of mid-tier companies that are as well positioned for the future as their larger competitors. The ones that are in a less strong position are often narrower in their geographic scope.”

Broader footprint success

“Companies with a broader footprint have tended to perform better over time as it helps to insulate them from climate volatility impacting key concentrations. In many cases, they also have more actuarial resources, for example, and more sophisticated products – deductible options, coverage options, and a holding company structure that allows them to have more rate flexibility and to shift risk across several operating companies.”

“He says the companies that are most exposed in what is currently a softening market exited the global pandemic years lacking the necessary systems, data, and actuarial talents as well as responsive management teams to make decisive decisions quickly. The mid-sized companies that had these in place have performed well. Those that didn’t are now having to try to catch up, and they are feeling the squeeze the most.”

Personal lines remains challenging

Speaking about the UK market, Saad Pervaiz who is an Associate Director at Fitch Ratings says the UK personal lines insurance market remains challenging: “Pricing is still under pressure as competition remains strong, while claims inflation is elevated and volatile, particularly in motor, where repair and labour costs, as well as supply chain pressures, continue to weigh on profitability.”

He says consolidation activity remains elevated. Insurers in the UK are looking for scale advantages, stronger efficiency, and broader earnings diversification. For example, he points out that “Aviva’s acquisition of DLG is a recent example of this, reflecting the strategic value of scale in personal lines through cost synergies, capital benefits, and greater market reach.”

He adds that companies are using targeted acquisitions to diversify their earnings and to strengthen their capabilities. “Admiral’s acquisition of More Than’s pet and home insurance business broadens its product mix, while its acquisition of Flock expands its presence in commercial fleet and adds technology-led capability,” he explains.

Personal lines scale imperative

Giuseppe (Beppe) Di Riso, Managing Director, Head A&M FSI Switzerland, Co-lead FSI DACH; Massimo Carassinu, Managing Director, A&M FSI Zurich; and Dominic Roope, Managing Director, A&M FSI London explains that the scale imperative particularly exists in personal lines. They explain that without scale, the margin scissors (i.e. the costs vis falling primary pricing power) go on.

Their analysis is that implicit consolidation, even without regulatory mandates, means the technology debt and misaligned reinsurance cycles are forcing M&A as the only path to survival. As for scale of focus, they argue that specialisation only works if you a dominant number 1 or 2 players in a specific complex line. So being a medium-sized generalist is no longer a viable strategy.

Then there is the equation of compressing bargaining power vs distribution. “Massive PE-backed brokers and MGAs are consolidating, hence eroding margins of mid-tier carriers,” they claim. On top of all this is the supervisory requirements of regulators about capital add-ons, ORSA scrutiny, recovery and resolution planning under IRRD, operational resilience testing, and conduct remediation.

“The marginal costs of compliance are increasing in absolute and relative terms, so we see increasing consolidation pressure in UK personal lines and in German and Italian mid-market non-life,” they reveal.

Balance sheet flexibility and diversification

An example is Liverpool Victoria. Remaining independent can only occur when there is sufficient balance sheet flexibility and diversification. The company lacked the scale to keep absorbing regulatory and capital costs as an independent, so the most viable option was to sell to a global insurer.

Mario Conde, partner in Bain & Company’s Financial Services practice says, “Bain’s 2026 global M&A Report shows that financial services is experiencing a pattern visible across capital-heavy industries: scale consolidation driven by the need to amortise regulatory and technology investment across larger volumes.”

He says the report shows “a close analogue to insurance in terms of capital intensity and regulatory overhead – M&A deals that combined both increased scale and widened capabilities, generated roughly 30% better gains in valuation than deals that pursued either just the scope or scale dimension alone.” His team believes this same dynamic is visible in UK personal lines.

“For mid-tier insurers still weighing their options, the window for acting from a position of strength, rather than reacting to deteriorating capital adequacy or regulatory pressure, is narrowing faster than many boards may appreciate,” he warns.

Abbe adds: “We certainly see M&A being a key topic across the board. The largest companies want to create fast growth, but the medium-sized companies are also looking to be an acquirer. The smaller companies want actuarial talent, data, technology, and geographic spread, and so they want to either be acquired or to be affiliated with the mid-sized to larger companies to improve their capabilities.”

Boards: sufficiently realistic?

As for whether Boards of mid-tier insurers are being sufficiently realistic about their strategic options – growth, partnership, consolidation, or orderly exit, or deferring difficult decisions, the Alvarez’s team comments that many are not.

“The most common pattern we observe is incremental optimism — successive three-year plans that assume combined ratio improvement, expense ratio reduction and modest growth simultaneously, year after year, without any of them materialising,” they remark.

They find that Boards tend to defer the harder conversations such as partnership, sale, portfolio transfer, and orderly run-off because each of those outcomes implicates hard decisions. “Boards that act in year one of underperformance preserve optionality; those that wait until year three are negotiating from weakness,” they suggest.

Abbe says that the challenge for Boards today, perhaps both in the US and in the UK, as well as elsewhere in the world, is that the future market cycles are going to happen faster than they did in the past. He therefore advises Boards to help their companies to success by moving more quickly. An example of this is the recent shifting of the Board conversations from profitability to growth.

The trouble is that if everyone looks to grow simultaneously, the speed of the market cycle becomes accelerated. He therefore concludes: “A realistic Board understands that they need to help their management teams to move fast, and to move quickly. If they don’t back nimble decision-making, then they are unlikely to be realistic with their expectations of future performance.” Boards that are sensible will succeed and avoid the squeeze.